Taysha Gene Therapies, Inc. ( TSHA) - Stock Earnings
TSHA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
TSHA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -27.9 million USD | 5.5 million USD |
| 2026Q1 | -42.4 million USD | — USD |
| 2026Q2 | -46.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TSHA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -111.6 million USD | 15.5 million USD |
| 2024 | -89.3 million USD | 8.3 million USD |
| 2025 | -109.0 million USD | 9.8 million USD |
| 2026 Est. | — | — |
TSHA
Price: $3.73
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 1.4 billion